University of Malaga
Also known as: Distrito de Atención Primaria Málaga-Valle del Guadalhorce | Distrito Sanitario Málaga- Guadalhorce. Servicio Andaluz de Salud | Dr. Manuel González-Sánchez | Faculty of Health Sciences, University of Málaga, Spain | Hospital Carlos Haya, Malaga | Hospital Carlos Haya. Malaga | Hospital Carlos Haya - Malaga - SPAIN | Hospital Regional de Malaga | Hospital Regional Universitario de Malaga | Hospital Regional Universitario de Málaga | Hospital Regional Universitario de Málaga - FIMABIS | Hospital Regional Universitario de Málaga, FIMABIS | Hospital Regional Universitario de Malaga Spain | Hospital Regional universitario de Malaga. UGC Salud Mental. | Hospital Universitario Virgen de la Victoria | Hospital Universitario Virgen de la Victoria de Málaga | Hospital Universitario Virgen de la Victoria, Malaga | Hospital Universitario Virgen de la Victoria. Malaga | Hospital Universitario Virgen de la Victoria. Malaga. Spain | Hospital Universitario y Regional de Málaga y Virgen de la Victoria | H. Virgen de la Victoria - Malaga | IMABIS Foundation. Hospital Carlos Haya. Malaga | Instituto de Investigacion Biomedica de Malaga | Instituto de Investigación Biomédica de Málaga (IBIMA). | JOSE MIGUEL MORALES ASENCIO | Malaga U | Universidad de Málaga | University of Malaga | University of Malaga; Malaga, Spain. | University of Malaga, Spain | University of Málaga (Spain) | Virgen de la Victoria Hospital, E-29010 Malaga, Spain | Virgen de la Victoria Hospital, Malaga | Virgen de la Victoria University Hospital
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2005Last known activity
Feb 15, 2024
Timeline
1970s
- Jun 1, 1972
University of Malaga— Founded
Drugs by trial phase (44 distinct, 28 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Aphasia
- Breast Neoplasms
- Cardiac Output, Low
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Communicable Diseases
- Coronavirus Infections
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diabetic Foot
- Eczema
- Erectile Dysfunction
- Food Hypersensitivity
- Foot Ulcer
- Fragile X Syndrome
- Glioblastoma
- Head and Neck Neoplasms
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hypersensitivity
- Hypogonadism
- Infections
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lupus Nephritis
- Mucositis
- Nephritis
- Obesity
- Prostatic Neoplasms
- Recurrence
- Sarcoma
- Severe Acute Respiratory Syndrome
- Stomatitis
- Stroke
- Syndrome
- Ulcer
Recent trials (37)
- NCT07131410Sponsor investigatorN/AFeb 15, 2024
- NCT07131410Lead sponsorN/AFeb 15, 2024
- NCT05673811OfficialPhase 2Jan 10, 2023
- NCT05472753OfficialN/ANov 16, 2022
- NCT05144646Lead sponsorN/AJan 4, 2022
- NCT05144646Sponsor investigatorN/AJan 4, 2022
- NCT05144646Overall official - principal investigatorN/AJan 4, 2022
- NCT04812457Overall official - principal investigatorEarly Phase 1Mar 6, 2021
- NCT04812457Lead sponsorEarly Phase 1Mar 6, 2021
- NCT04812457Reponsible party - principal investigatorEarly Phase 1Mar 6, 2021
- NCT04293393Study directorPhase 2Jun 30, 2020
- NCT04400019Reponsible party - principal investigatorPhase 2/Phase 3May 15, 2020
- NCT04400019Overall official - principal investigatorPhase 2/Phase 3May 15, 2020
- NCT04400019Lead sponsorPhase 2/Phase 3May 15, 2020
- NCT04179604Overall official - principal investigatorPhase 2/Phase 3Dec 31, 2019
Details
- Founded
- Malaga, ES Jun 1, 1972
- Last known activity
- Feb 15, 2024